Employees
~500
Therapeutic Areas
EndocrinologyOncologyCardiovascularNeurology
Stage
Commercial
Modalities
Autologous cell therapyGene therapy

OmniaBio General Information

Commercial-scale CDMO for cell and gene therapy manufacturing with AI-enabled development capabilities

Contact Information

Website
Primary Industry
CDMO
Corporate Office
Hamilton, Ontario
Canada

Drug Pipeline

No pipeline data available

For full access to OmniaBio's pipeline data

Book a demo

Key Partnerships

Medipost, CCRM, UHN, Cytiva, University of Toronto, CellCAN

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

OmniaBio Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view OmniaBio's complete valuation and funding history, request access »